edoc

Hodgkin lymphoma treatment with ABVD in the US and the EU: neutropenia occurrence and impaired chemotherapy delivery

Schwenkglenks, Matthias and Pettengell, Ruth and Szucs, Thomas D. and Culakova, Eva and Lyman, Gary H.. (2010) Hodgkin lymphoma treatment with ABVD in the US and the EU: neutropenia occurrence and impaired chemotherapy delivery. Journal of hematology & oncology, Vol. 3. p. 27.

Full text not available from this repository.

Official URL: http://edoc.unibas.ch/dok/A6004764

Downloads: Statistics Overview

Abstract

In newly diagnosed patients with Hodgkin lymphoma (HL) the effect of doxorubicin, bleomycin, vinblastine and dacarbazine (ABVD)-related neutropenia on chemotherapy delivery is poorly documented. The aim of this analysis was to assess the impact of chemotherapy-induced neutropenia (CIN) on ABVD chemotherapy delivery in HL patients.
Faculties and Departments:03 Faculty of Medicine > Departement Public Health > Pharmazeutische Medizin ECPM > Pharmazeutische Medizin (Szucs)
UniBasel Contributors:Schwenkglenks, Matthias
Item Type:Article, refereed
Article Subtype:Research Article
Publisher:Biomed Central
Note:Publication type according to Uni Basel Research Database: Journal article
Last Modified:24 May 2013 09:23
Deposited On:24 May 2013 09:21

Repository Staff Only: item control page